U.S. Markets close in 4 hrs, 22 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,233.37 | 6.43 | 0.06% |
| NASDAQ | 2,148.32 | -5.74 | -0.27% |
| S&P 500 | 1,091.13 | -1.95 | -0.18% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | 0.08 | Current P/E Ratio: | 11.25 |
|---|---|---|---|
| Last Quarter's Earnings: | 0.01 | Current Quarter Estimate: | -0.085 |
| Last Fiscal Year Earnings: | -1.17 | Next Fiscal Year Estimate: | -0.40 |
| Analyst Consensus: | Strong Buy | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Strong Buy
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 03/08/2010 * | 18:00 | Q4 2009 Keryx Biopharmaceuticals, Inc. Earnings Release |  |
| 11/10/2009 | 21:40 | Keryx Biopharmaceuticals, Inc. at Merriman Curhan Ford Investor Summit | |
| 11/10/2009 | 14:30 | Q3 2009 Keryx Biopharmaceuticals, Inc. Earnings Conference Call | |
| 11/10/2009 | 15:30 | Q3 2009 Keryx Biopharmaceuticals, Inc. Earnings Conference Call | |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/09/2009 | Q3 2009 Keryx Biopharmaceuticals, Inc. Earnings Release | — | — |
| 11/04/2009 | Keryx Biopharmaceuticals, Inc. at Oppenheimer & Co. Healthcare Conference |  |
— |
| 09/09/2009 | Keryx Biopharmaceuticals, Inc. at Rodman & Renshaw Annual Global Investment Conference | |
— |
| 08/06/2009 | Q2 2009 Keryx Biopharmaceuticals, Inc. Earnings Conference Call | |
Download($) |
| 08/05/2009 | Q2 2009 Keryx Biopharmaceuticals, Inc. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts